Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemia.

Am J Hematol · 2022 · PMC9303262 · PMID 35150150

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a trend toward significanceno p-value reported

4 In the MRC cohort, CBF‐AML patients who completed all FLAG‐ and HDAC‐based induction/consolidations had stellar outcomes 37 In our cohort also on comparing TTNT between Groups 1 and 2; there was a significant difference in the OS and there was a trend toward significance in TTNT between these two groups.

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.